Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Patient Education and Counseling|December 20, 2015
Kidney transplant patients' attitudes towards self-management support: A Q-methodological studyJ W Grijpma, M Tielen, A L van Staa, et al.
Transplantation|March 4, 1998
Blockade of the interleukin (IL)-2/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humansT van Gelder, C C Baan, A H Balk, et al.
Clinical and Experimental Immunology|May 3, 2002
Down-regulated donor-specific T-cell reactivity during successful tapering of immunosuppression after kidney transplantationN M van Besouw, B J van der Mast, P de Kuiper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2011
Imatinib treatment duration is related to decreased estimated glomerular filtration rate in chronic myeloid leukemia patientsM S Marcolino, E Boersma, N C D Clementino, et al.
Clinical Pharmacology and Therapeutics|September 12, 2008
Genetic variation in the CYP2D6 gene is associated with a lower heart rate and blood pressure in beta-blocker usersM J Bijl, L E Visser, R H N van Schaik, et al.
Expert Opinion on Drug Metabolism & Toxicology|April 16, 2016
Pharmacokinetic considerations and recommendations in palliative care, with focus on morphine, midazolam and haloperidolL G Franken, B C M de Winter, H J van Esch, et al.
Transplantation|August 10, 1999
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantationT van Gelder, L B Hilbrands, Y Vanrenterghem, et al.
British Journal of Clinical Pharmacology|December 16, 2018
A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipientsL M Andrews, D A Hesselink, R H N van Schaik, et al.
Alimentary Pharmacology & Therapeutics|November 14, 2008
The effects of guideline implementation for proton pump inhibitor prescription on two pulmonary medicine wardsE P M van Vliet, E W Steyerberg, H J A M Otten, et al.
Clinical Pharmacology and Therapeutics|June 5, 2009
UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patientsR H N van Schaik, M van Agteren, J W de Fijter, et al.
Pageof 12